No Data
Shenzhen Neptunus Bioengineering (000078.SZ): The company's current medical device business is approximately 10 billion yuan in size.
Gelonghui November 13th | Shenzhen Neptunus Bioengineering (000078.SZ) stated in investor relations that the medical device distribution business has a higher gross profit level compared to the pharmaceutical distribution business, with relatively minor influence from policies. Therefore, the medical devices business is one of the company's key development sectors, with the current medical device business size reaching about tens of billions. In the future, the company will expand the scale of medical device distribution and agency business, aiming to transition from market agents to entities with the right to represent foreign brands, by introducing advanced technology and high-quality products from foreign brands to further enhance the company's level and competitiveness in the medical device business.
Shenzhen Neptunus Bioengineering Co., Ltd. (SZSE:000078) Surges 31% Yet Its Low P/S Is No Reason For Excitement
Neptune Biotech: Report for the third quarter of 2024
shenzhen neptunus bioengineering (000078.SZ): the net income in the first three quarters was 46.2173 million yuan, a year-on-year decrease of 47.77%.
On October 30, Gelonghui│ Shenzhen Neptunus Bioengineering (000078.SZ) released the third quarter report for 2024, with the company achieving revenue of 24.553 billion yuan in the first three quarters, a year-on-year decrease of 14.27%; net income attributable to shareholders of the listed company was 46.2173 million yuan, a year-on-year decrease of 47.77%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 19.7353 million yuan, a year-on-year decrease of 53.72%; basic earnings per share were 0.0176 yuan.
Investors in Shenzhen Neptunus Bioengineering (SZSE:000078) From Five Years Ago Are Still Down 18%, Even After 13% Gain This Past Week
Neptune Biotech: 2024 Semi-Annual Report Summary
Further Weakness as Shenzhen Neptunus Bioengineering (SZSE:000078) Drops 5.4% This Week, Taking Five-year Losses to 46%
